Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05267106 |
|---|---|
| Brief Title: | Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations (FIGHT-209) |
| First Submitted : | February 15, 2022 |
| First Submitted that Met QC Criteria : | February 23, 2022 |
| First Posted : | March 4, 2022 |
| Last Update Submitted that Met QC Criteria : | December 1, 2022 |
| Last Update Posted : | December 2, 2022 |